The major targets for PD drug development for management include the LRRK2, neurotrophic factors, alpha-synuclein, cell therapy, antioxidants, the microbiome, and GIT and dopamine precursors that will be the futuristic approaches to overcome PD [94]. This evidence concerns the gene LRRK2 and Parkinson disease.